# EIGER BIOPHARMACEUTICALS INC: Form D filings

EIGER BIOPHARMACEUTICALS INC, a biotechnology company in Palo Alto, CA, filed 10 Form D notices with the SEC between 2010 and 2015. The latest, on November 20, 2015, reports $6 million sold of a $6 million offering to 4 investors.

Find out what EIGER BIOPHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EIGER%20BIOPHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EIGER%20BIOPHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Feiger-biopharmaceuticals-inc-1454815)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EIGER%20BIOPHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EIGER%20BIOPHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Feiger-biopharmaceuticals-inc-1454815)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 350 Cambridge Avenue, Suite 350, Palo Alto, CA, 94306
- Phone: (650) 272-6138
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1454815

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 20, 2015 | New notice | $6,000,000 | $6,000,000 | $0 | 4 | Nov 12, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481515000004/0001454815-15-000004-index.htm) |
| Mar 24, 2015 | Amendment | $14,603,554 | $14,462,851 | $140,703 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481515000002/0001454815-15-000002-index.htm) |
| Feb 17, 2015 | Amendment | $9,048,000 | $8,740,630 | $307,370 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481515000001/0001454815-15-000001-index.htm) |
| Nov 20, 2014 | Amendment | $7,257,161 | $7,240,631 | $16,530 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000129674314000002/0001296743-14-000002-index.htm) |
| Sep 5, 2014 | Amendment | $7,117,217 | $6,913,123 | $204,094 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481514000002/0001454815-14-000002-index.htm) |
| Apr 11, 2014 | Amendment | $5,872,773 | $5,813,123 | $59,650 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481514000001/0001454815-14-000001-index.htm) |
| May 14, 2013 | Amendment | $5,372,769 | $5,313,122 | $59,647 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481513000001/0001454815-13-000001-index.htm) |
| Aug 29, 2012 | Amendment | $5,000,000 | $4,557,568 | $442,432 | 8 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481512000001/0001454815-12-000001-index.htm) |
| Apr 27, 2011 | New notice | $5,000,000 | $3,550,000 | $1,450,000 | 4 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481511000001/0001454815-11-000001-index.htm) |
| Sep 20, 2010 | Amendment | $8,300,000 | $8,300,000 | $0 | 9 | Dec 10, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1454815/000145481510000002/0001454815-10-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas Dietz | Director |  |
| David Cory | Executive Officer, Director |  |
| Nina Kjellson | Director |  |
| Ed Engleman | Director |  |
| Jeffrey Glenn | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Nov 16, 2015](https://specstream.ai/data/form-d/week/2015-11-16) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what EIGER BIOPHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).